196 related articles for article (PubMed ID: 23195419)
1. Current status of clinical trials of neural transplantation in Parkinson's disease.
Evans JR; Mason SL; Barker RA
Prog Brain Res; 2012; 200():169-98. PubMed ID: 23195419
[TBL] [Abstract][Full Text] [Related]
2. The future of cell therapies in the treatment of Parkinson's disease.
Laguna Goya R; Kuan WL; Barker RA
Expert Opin Biol Ther; 2007 Oct; 7(10):1487-98. PubMed ID: 17916042
[TBL] [Abstract][Full Text] [Related]
3. Cell transplantation in Parkinson's disease: problems and perspectives.
Allan LE; Petit GH; Brundin P
Curr Opin Neurol; 2010 Aug; 23(4):426-32. PubMed ID: 20489615
[TBL] [Abstract][Full Text] [Related]
4. Neural grafting in Parkinson's disease unraveling the mechanisms underlying graft-induced dyskinesia.
Lane EL; Björklund A; Dunnett SB; Winkler C
Prog Brain Res; 2010; 184():295-309. PubMed ID: 20887881
[TBL] [Abstract][Full Text] [Related]
5. Cellular replacement therapy for Parkinson's disease--where we are today?
Redmond DE
Neuroscientist; 2002 Oct; 8(5):457-88. PubMed ID: 12374430
[TBL] [Abstract][Full Text] [Related]
6. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease.
Barker RA; Barrett J; Mason SL; Björklund A
Lancet Neurol; 2013 Jan; 12(1):84-91. PubMed ID: 23237903
[TBL] [Abstract][Full Text] [Related]
7. Graft-induced dyskinesias in Parkinson's disease: what is it all about?
Barker RA; Kuan WL
Cell Stem Cell; 2010 Aug; 7(2):148-9. PubMed ID: 20682443
[TBL] [Abstract][Full Text] [Related]
8. Neural grafting in Parkinson's disease Problems and possibilities.
Brundin P; Barker RA; Parmar M
Prog Brain Res; 2010; 184():265-94. PubMed ID: 20887880
[TBL] [Abstract][Full Text] [Related]
9. Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective.
Hagell P; Cenci MA
Brain Res Bull; 2005 Dec; 68(1-2):4-15. PubMed ID: 16324999
[TBL] [Abstract][Full Text] [Related]
10. Neural transplantation for the treatment of Parkinson's disease.
Björklund A; Dunnett SB; Brundin P; Stoessl AJ; Freed CR; Breeze RE; Levivier M; Peschanski M; Studer L; Barker R
Lancet Neurol; 2003 Jul; 2(7):437-45. PubMed ID: 12849125
[No Abstract] [Full Text] [Related]
11. Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients.
Levivier M; Dethy S; Rodesch F; Peschanski M; Vandesteene A; David P; Wikler D; Goldman S; Claes T; Biver F; Liesnard C; Goldman M; Hildebrand J; Brotchi J
Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):99-111. PubMed ID: 9711741
[TBL] [Abstract][Full Text] [Related]
12. Trials offer way forward for Parkinson's.
Abbott A
Nature; 2001 Mar; 410(6827):401. PubMed ID: 11260676
[No Abstract] [Full Text] [Related]
13. Parkinson's transplant therapy faces setback.
Check E
Nature; 2003 Aug; 424(6952):987. PubMed ID: 12944933
[No Abstract] [Full Text] [Related]
14. Transplantation therapy for Parkinson's disease.
Borlongan CV
Expert Opin Investig Drugs; 2000 Oct; 9(10):2319-30. PubMed ID: 11060809
[TBL] [Abstract][Full Text] [Related]
15. Dyskinesias following neural transplantation in Parkinson's disease.
Hagell P; Piccini P; Björklund A; Brundin P; Rehncrona S; Widner H; Crabb L; Pavese N; Oertel WH; Quinn N; Brooks DJ; Lindvall O
Nat Neurosci; 2002 Jul; 5(7):627-8. PubMed ID: 12042822
[TBL] [Abstract][Full Text] [Related]
16. Can human fetal cortical brain tissue transplant (up to 20 weeks) sustain its metabolic and oxygen requirements in a heterotopic site outside the brain? A study of 12 volunteers with Parkinson's disease.
Bhattacharya N; Chhetri MK; Mukherjee KL; Ghosh AB; Samanta BK; Mitra R; Bhattacharya M; Bhattacharya S; Bandopadhyaya T
Clin Exp Obstet Gynecol; 2002; 29(4):259-66. PubMed ID: 12635741
[TBL] [Abstract][Full Text] [Related]
17. Designing stem-cell-based dopamine cell replacement trials for Parkinson's disease.
Barker RA;
Nat Med; 2019 Jul; 25(7):1045-1053. PubMed ID: 31263283
[TBL] [Abstract][Full Text] [Related]
18. Dyskinesias after neural transplantation in Parkinson's disease: what do we know and what is next?
Politis M
BMC Med; 2010 Dec; 8():80. PubMed ID: 21126348
[TBL] [Abstract][Full Text] [Related]
19. Brain imaging after neural transplantation.
Politis M; Piccini P
Prog Brain Res; 2010; 184():193-203. PubMed ID: 20887876
[TBL] [Abstract][Full Text] [Related]
20. Graft-induced dyskinesias fail to respond to 5HT1A agonist in the long-term.
Beaulieu-Boire I; Fasano A
Mov Disord; 2015 May; 30(6):872-3. PubMed ID: 25758209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
